Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127823191 | 12782319 | 1 | I | 20160917 | 20160927 | 20160927 | EXP | ES-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK024403 | GLENMARK | LARRANAGA AC, ABIAN FN, PEREZ MB, GARCIA FS, URTASUN MM, BARRENETXEA AJ, GASTON MB, SAFONT GA. SEVERE PREECLAMPSIA: ACCORDING TO A CLINICAL CASE.. 25TH EUROPEAN CONGRESS OF PERINATAL MEDICINE. 2016;29:266-267 | 41.00 | YR | F | Y | 0.00000 | 20160927 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127823191 | 12782319 | 1 | PS | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | Unknown | UNK | U | 78930 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127823191 | 12782319 | 1 | Maternal therapy to enhance foetal lung maturity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127823191 | 12782319 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127823191 | 12782319 | Exposure during pregnancy | |
| 127823191 | 12782319 | Pre-eclampsia | |
| 127823191 | 12782319 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |